VOR - מדד נזילות מהירה vorbio.com

The price chart for Vor Biopharma Inc. (VOR) reflects the impact of positive data from initial bone marrow protection system tests, with the current indicator standing at 19.76. The business relies on partnerships with transplant centers to create synergy in cell editing. Complex biosyntheses and patent protection ensure a high barrier to entry, effectively excluding new players.

The quick ratio is calculated as the ratio of cash and accounts receivable to current liabilities, completely excluding illiquid inventories. This coefficient serves as a stringent indicator of financial stability and the company's ability to promptly settle its debts. For Vor Biopharma Inc. (VOR), this margin of safety is critical until the commercialization of its unique cell therapy. The trend in the average quick ratio allows for an assessment of the capital burn rate for research and development.